TerminatedNCT03854942
Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System
Medication studyAges 21–45GermanyAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 45 years.
- Listed locations
- AachenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: August 30, 2011
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 43
- Sponsor
- RWTH Aachen University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Germany
- Age range
- From 21 Years to 45 Years
- Official registry ID
- NCT03854942
- Official title
Show the full official title
Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System: a [18F]-Fallypride- and [18F]-Fluoro-DOPA-PET Study.
Recruitment & locations
TerminatedAachen
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is RWTH Aachen University, a university.
Does this study involve medication?
Yes. The study involves medication, including Placebo and Naltrexone.
Who can participate?
Listed age limits: 21 years to 45 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
A five year non-residential multi-centre observational study conducted to track any changes in mouth level exposure and salivary and urinary biomarkers from healthy smokers smoking in their normal environment
Addiction Risk: Mindset Induction Effect on Brief Intervention
